Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 2/20 | 0.46 |
| ▸ | NOS1 | P29475 | 2/20 | 0.46 |
| ▸ | NOS2 | P35228 | 2/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 8/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 7/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 7/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 7/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 7/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 7/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 7/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 7/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 7/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 7/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL778106 | 0.88 | HPGD (0.54) | HDAC8HDAC6SMN1; SMN2KMT2AALDH1A1 | |
| SCHEMBL14114091 | 0.87 | ALDH1A1 (0.54) | NOS3NOS1NOS2HDAC8HDAC6 | |
| SCHEMBL1641518 | 0.84 | HDAC3 (0.55) | NOS3NOS1NOS2HDAC8HDAC6 | |
| SCHEMBL7527942 | 0.84 | HDAC3 (0.63) | NOS3NOS1NOS2HDAC8HDAC6 | |
| SCHEMBL69963 | 0.83 | SMN1; SMN2 (0.44) | NOS3NOS1NOS2SMN1; SMN2KMT2A | |
| SCHEMBL24703568 | 0.81 | HDAC3 (0.44) | NOS3NOS1NOS2HDAC8HDAC6 | |
| SCHEMBL24703569 | 0.81 | PTPN1 (0.44) | NOS1HDAC8HDAC6HDAC3HDAC4 | |
| SCHEMBL1479121 | 0.80 | KMT2A (0.40) | NOS3NOS1NOS2HDAC8HDAC6 | |
| SCHEMBL5830962 | 0.80 | CYP3A4 (0.43) | NOS3NOS1NOS2HDAC8HDAC6 | |
| SCHEMBL27501402 | 0.76 | ALDH1A1 (0.49) | NOS3NOS1NOS2KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119044866-A | Revising method of atmospheric electric field monitoring result | 无锡学院 | 2024-11-29 | — | — | CN | claimed |
| US-11648382-B2 | Microneedle structure and manufacturing method and manufacturing apparatus for the same | KOREA INSTITUTE OF MACHINERY & MATERIALS (KR) | 2023-05-16 | — | — | US | claimed |
| CN-114613011-A | Human body 3D (three-dimensional) bone behavior identification method based on graph attention convolutional neural network | 东华大学 | 2022-06-10 | — | — | CN | claimed |
| CN-114239370-A | Method for calculating critical space ion flow field of large wind turbine generator in thunderstorm process | 华北电力大学 | 2022-03-25 | — | — | CN | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-20260139275-A1 | STEM CELL BASED DELIVERY OF TUMOR-SPECIFIC RETROVIRAL VECTORS | THE REGENTS OF THE UNIV OF CALIFORNIA (US) | 2026-05-21 | — | — | US | disclosed |
| EP-3987386-B1 | ADAPTIVE HOVER OPERATION OF TOUCH INSTRUMENTS | MICROSOFT TECHNOLOGY LICENSING LLC (US) | 2026-03-25 | — | — | EP | disclosed |
| US-20260073128-A1 | System and Method for Generating and Publishing Electronic Content from Predetermined Templates | 1206881 ALBERTA LTD. (CA) | 2026-03-12 | — | — | US | disclosed |
| US-12528065-B2 | Nanocapsules and process of making and using same | The Government of the United States, as represented by the Director of the Defense Health Agency (US) | 2026-01-20 | — | — | US | disclosed |
| US-12443789-B2 | System and method for generating and publishing electronic content from predetermined templates | 1206881 ALBERTA LTD. (CA) | 2025-10-14 | — | — | US | disclosed |
| US-20020102215-A1 | Diagnostic/therapeutic agents | NYCOMED IMAGING AS | 2002-08-01 | — | — | US | disclosed |
| US-20020102217-A1 | Diagnostic/therapeutic agents | NYCOMED IMAGING AS | 2002-08-01 | — | — | US | disclosed |
| US-6331289-B1 | ULTRASOUND CONTRAST AGENTS, SUSPENSION IN AQUEOUS CARRIER LIQUID OF A REPORTER COMPRISING GAS-CONTAINING OR GAS-GENERATING MATERIAL, AGENT CAPABLE OF FORMING AT LEAST TWO TYPES OF BINDING PAIRS WITH TARGET; REPORTER BEING CONJUGATED | NYCOMED IMAGING AS (NO) | 2001-12-18 | — | — | US | disclosed |
| US-6264917-B1 | MIXTURE OF GAS FILLED MICROBUBBLES AND RELEASING AGENT | NYCOMED IMAGING AS (NO) | 2001-07-24 | — | — | US | disclosed |
| US-6261537-B1 | TARGETS AND ULTRASOUND DIAGNOSIS OF ACTIVE MATERIALS, AQUEOUS CARRIER LIQUIDS, CARRIERS AND FILM FORMING SURFACTANT PHOSPHATIDES | NYCOMED IMAGING AS (NO) | 2001-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260073128-A1 | System and Method for Generating and Publishing Electronic Content from Predetermined Templates | CFL1, EMD, TEC | NOS3 3036/4885NOS1 2783/4885NOS2 2721/4885 |
| US-20260139275-A1 | STEM CELL BASED DELIVERY OF TUMOR-SPECIFIC RETROVIRAL VECTORS | MYC, MYCBP, FUS | NOS3 4658/4885NOS1 4595/4885NOS2 4546/4885 |
| US-12528065-B2 | Nanocapsules and process of making and using same | PTEN, PHOSPHO1, CAD | NOS3 83/4885NOS1 581/4885NOS2 215/4885 |
| US-20020102215-A1 | Diagnostic/therapeutic agents | BID, FUS, FABP1 | NOS3 4103/4885NOS1 4058/4885NOS2 4290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.